Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of VEREGEN 10% is insufficient in the Marketing Authorisation indication. |
eNq1mF1v2jAUhu/5FVEudkcSSimwJVQbazekVmMUtGk3yCQHMAt26g8++uvnELrC5KirwZeJk/cc+xw/fuXwerNMnRUwjimJ3JoXuA6QmCaYzCJ3NLytttzrTiVcoBU6+KzpBV7twnXiFHEeufmoNwFEuPfz/u4zqP+BuZ2KE9LJAmJx9J0UOPW+Ij6/R1n+jROuKE6cJYg5TSI3k2L31gm5YCqLzpqy3zxDMYT+/s3h6GJ8efg+9HOx/1CVHNgdIjOtKBAjzVgyBkR0kYAZZduSfOtG2pgPgFPJYugjMe8zusIJJNoQU5RyMAoyXScPwFYpiDyIVtxfxEtuJI4WaDOAx54+6Y9qtCs2ohpUa81mK2gHrWbQagdGodjBUumroCbhx+Na86rRrtd9IL7qbZgZ1h3zPmUCpZaqgnn3uLEsxWHw+Gr1E8yzFG29Bc9MlwoxpIaBqe1vbyL5DIZMASlVa/aPPpFp6r8x69EeF5YyzmnUpZKIEmrcDkwXokuJgE15Rc1AJzb7XsTAzyf7RIke8n05SXFsijQFHQlcjAa9cqKdEwafEIcRs0eDH5gkdM3PT5nDqlrKPtuBUiuasaQ2vmi3rmqNhvEm+qVaqOSEuZGMZuAr/mB+ClZ6ZEpPBYrqSr3Uc0+erR13PofGKIUSp1M1ZIvqw2djZq3T7e2iYkAr+uVmaNoe3yWw7cPuUSuNk+hvYc3Aa4PmqhlfS7zYtlE2rgeNVrt++Q4tsw/PFjoybM1C1IpblkzPmLkQGX/v++v12psjXuVIrac3ZeVnwLV26ueYvgLuSzXtGXorBqAwRAVsLaU+KU7Rt5XRdOO+ZhFOtb37//f2WhtDMAkn1KJgvDUS927OD/cXz2st7f4RYuyF2flTJDAltnyTnGgVTztOVF3JLVOA+Dad4pILltK+DP3icqdTCf38YqdT+QN3yQCC
4jv3Db0VYbBXmPSL
